Heparan sulfate proteoglycan, such as Glypican-1 (GPC-1), has been reported as a potential pancreatic cancer (PC) biomarker [74] as its expression is greater in human PC than normal cells [75]. The gene discussed is GPC1; the disease is pachyonychia congenita.